Search for: "Schering Corp"
Results 241 - 251
of 251
Sort by Relevance
|
Sort by Date
24 Apr 2007, 1:18 am
.; Schering Corp. v. [read post]
23 Apr 2007, 2:25 am
Schering-Plough Sued in N.J. for Marketing Drugs for Off-Label Uses A raft of lawsuits centered in New Jersey allege Schering-Plough Corp. offered bribes, kickbacks and other incentives to doctors to get them to prescribe its hepatitis and cancer drugs for uses not approved by the Food and Drug Administration Racial-Profiling Claim Gets Priority Over State's Attenuation Argument A criminal defendant is entitled to… [read post]
3 Apr 2007, 6:20 am
(noting that "Switzerland's Serono and Germany's Schering, Altana and Schwarz were all sold in 2006" and that "Britain's Astra Zeneca and America's Wyeth and Bristol-Myers Squibb" may be the next targets for larger, acquiring firms) [read post]
27 Mar 2007, 9:49 am
Schering-Plough Corp., the Solicitor General concluded that no conflict exists that would warrant this Court's review of this issue, based on the same body of case law that exists today. [read post]
20 Mar 2007, 8:19 am
**Separately**Patently-O notes the Supreme Court has requested the Solicitor General to brief issues in Tamoxifen Citrate Antitrust Litigation, a sequel to the earlier much-discussed Schering Plough case in the 11th Circuit. [read post]
14 Nov 2006, 6:06 am
Corp Fin No-Action Letter: Novel Tender Offer Relief In this no-action letter, the SEC Staff granted relief in connection with Bayer's tender offer for Schering to permit the bidder to provide for a two-month subsequent offering period. [read post]
10 Nov 2006, 2:32 pm
The classic case on this point is Titanium Metals Corp. v. [read post]
16 Oct 2006, 7:58 pm
Schering-Plough sued over a dozen companies who filed ANDA's to market generic versions of Clarinex. [read post]
21 Sep 2006, 9:51 am
" SmithKline, 403 F.3d at 1343 (citations omitted); see also Schering, 339 F.3d at 1377 (holding that "inherent anticipation does not require that a person of ordinary skill in the art at the time would have recognized the inherent disclosure"); MEHL/Biophile Int'l Corp. v. [read post]
7 Jul 2006, 5:00 pm
As summarized in the April, 2005 edition of the Antitrust Law Blog, in Schering-Plough Corp. v. [read post]
30 Jul 2004, 1:16 pm
Drug manufacturer Schering-Plough Corp. agreed to a $345.5 million fine and to plead guilty that it overcharged the federal Medicaid program. [read post]
